Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Wilms tumors: Genetic triggers uncovered

10.02.2015

For childhood kidney tumors, scientists from Würzburg and Heidelberg have identified a series of previously unknown genetic causes. In so doing, they are paving the way for improved, customized treatment.

Wilms tumors, also known as nephroblastomas, are among the more common solid tumors in children. They tend to appear before the age of six and are categorized as embryonal tumors. The starting point in their development are kidney precursor cells in the embryo, which evidently do not mature as they should. Consequently, the tumor contains somewhat differing tissue structures, which is why the man who lent his name to them, Max Wilms, referred to “mixed tumors of the kidney” in his description in 1899.

In the search for the molecular causes of Wilms tumors and, in particular, the genetic culprits behind their high-risk variants, a group of scientists has now made a breakthrough. This collaboration involved teams led by Professor Manfred Gessler, chairman of the Department of Developmental Biochemistry at the University of Würzburg’s Biocenter, and teams led by Marcel Kool and Stefan Pfister at the German Cancer Research Center in Heidelberg as well as partners both within Germany and abroad. They present their findings in the current issue of the journal Cancer Cell.

Genetic defects slow down the molecular machinery

“Previously, three genes were known to be possible triggers of Wilms tumors. We have now managed to identify a whole series of other causes,” explains Manfred Gessler. These include the genes DROSHA and DGCR8. If these are defective, this leads to a partial deactivation of the molecular machinery responsible for creating so-called microRNAs. MicroRNAs, for their part, are able to regulate the function of a large number of messenger RNA molecules and thus completely reprogram cells.

“With embryonic stem cells we already know that without microRNAs they are not capable of transforming themselves into cells of different tissues,” says Gessler. The same seems to be true of Wilms tumors: in their case, individual kidney precursor cells evidently do not manage to mature fully. Instead they remain in an embryonic state in which rapid growth is one of their fundamental tasks so that the kidney grows.

A genetic defect triggers various cancers

Alongside the microRNAs, two transcription factors also attracted the attention of the teams. The proteins referred to as SIX1 and SIX2 control the activity of other genes. Animal models had already made it clear that they are absolutely vital to the formation of the kidneys; they are also particularly active in Wilms tumors. “Our findings now reveal for the first time that both genes for these transcription factors are altered in Wilms tumors by mutations and, as a result, the cells remain in an embryonic growth mode in this case, too,” explains Gessler.

Third finding of the study: Tumor genes that are known to trigger other cancers may also be responsible for Wilms tumors. The scientists were able to show that a particular gene involved in the development of neuroblastomas – tumors that arise from degenerated immature cells of the sympathetic nervous system – is also activated in Wilms tumors. “This gives real hope that treatments that are successful for a neuroblastoma will also be effective for Wilms tumors,” says Gessler

In addition, some of the Wilms tumors demonstrated a deactivation of the most familiar tumor suppressor gene TP53, which led to dramatic genome changes accompanied by the fracture and uncontrolled loss or multiplication of chromosomal fragments. The prognosis for such degenerated tumors is particularly unfavorable.

Approaches for personalized treatment

The scientists involved believe that the new findings relating to the various triggers of Wilms tumors may help to improve treatment. Currently around 90 percent of children with the disease survive if they receive a combination of chemotherapy, surgery, and then further chemotherapy. The trick here is to identify patients with so-called high-risk tumors early and to treat them more intensively than cases with a low discernible risk of relapse. This technique should minimize the stress on the children and any possible consequential harm.

A histologic examination, routinely conducted these days, and the clinical picture provide important indicators here. But these are still not enough. “Clarifying the molecular causes offers hope of improving the classification of tumors and of being able to use increasingly targeted treatments within the framework of personalized medicine,” says Manfred Gessler.

However, with some of these genetic changes that have now been discovered it remains unclear how they contribute to tumor development. The aim of future work will mainly be to filter out from the abundance of candidates those that are best suited to predicting the progression of the disease, and to develop approaches for tailor-made treatments based on new knowledge relating to molecular networks.

Ideal combination of different areas of expertise

For the study of Wilms tumors, the various disciplines of the teams involved complemented one another perfectly: The Würzburg team contributed years of experience in the analysis of Wilms tumors and one of the world’s largest collections of these tumors, which is housed at the Biocenter. The Heidelberg team, within the Heidelberg Center for Personalized Oncology (HIPO), provided extensive capacities and experience in high-throughput sequencing and genome analysis. The changes they discovered were then checked in Würzburg against hundreds of other tumors and their function examined.

Future work will require close collaboration with numerous pediatric clinics and pathologists as part of the German Wilms Tumor Study and with European partners, as this is the only way that it will be possible to collect and analyze sufficient material and data for such tumors successfully.

This work was supported by the Wilhelm-Sander-Stiftung foundation, the German Research Foundation, the Federal Ministry of Education and Research, and the HIPO initiative of the German Cancer Research Center (DKFZ-HIPO).

Mutations in the SIX1/2 Pathway and the DROSHA/DGCR8 miRNA Microprocessor Complex Underlie High-Risk Blastemal Type Wilms Tumors. Jenny Wegert, Naveed Ishaque, Romina Vardapour, Christina Geörg, Zuguang Gu, Matthias Bieg, Barbara Ziegler, Sabrina Bausenwein, Nasenien Nourkami, Nicole Ludwig, Andreas Keller, Clemens Grimm, Susanne Kneitz, Richard D. Williams, Tas Chagtai, Kathy Pritchard-Jones, Peter van Sluis, Richard Volckmann, Jan Koster, Rogier Versteeg, Tomas Acha, Maureen J. O’Sullivan, Peter Karl Bode, Felix Niggli, Godelieve A. Tytgat, Harm van Tinteren, Marry M. van den Heuvel-Eibrink, Eckart Meese, Christian Vokuhl, Ivo Leuschner, Norbert Graf, Roland Eils, Stefan M. Pfister, Marcel Kool, Manfred Gessler. Cancer Cell, http://dx.doi.org/10.1016/j.ccell.2015.01.002

Contact

Prof. Dr. Manfred Gessler, T: +49 (0)931 31-84159, gessler@biozentrum.uni-wuerzburg.de

Gunnar Bartsch | Julius-Maximilians-Universität Würzburg

More articles from Life Sciences:

nachricht Colorectal cancer risk factors decrypted
13.07.2018 | Max-Planck-Institut für Stoffwechselforschung

nachricht Algae Have Land Genes
13.07.2018 | Julius-Maximilians-Universität Würzburg

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

Im Focus: Chemical reactions in the light of ultrashort X-ray pulses from free-electron lasers

Ultra-short, high-intensity X-ray flashes open the door to the foundations of chemical reactions. Free-electron lasers generate these kinds of pulses, but there is a catch: the pulses vary in duration and energy. An international research team has now presented a solution: Using a ring of 16 detectors and a circularly polarized laser beam, they can determine both factors with attosecond accuracy.

Free-electron lasers (FELs) generate extremely short and intense X-ray flashes. Researchers can use these flashes to resolve structures with diameters on the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Research finds new molecular structures in boron-based nanoclusters

13.07.2018 | Materials Sciences

Algae Have Land Genes

13.07.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>